Cardiovascular adverse events
1 paper
- Human trial1
Latest
4 in 12 monthsPLOS One
Using dapagliflozin to reduce symptoms in transthyretin cardiac amyloidosis: An n-of-1 trial series pilot study
Non-randomised trial in 7 peopleDapagliflozin
Journal of the American Heart Association
Haptoglobin and Immunoglobulin A2 Predict Cardiovascular Risk in Asymptomatic Subjects: The BioImage Study
Cohort study of 5,328 peopleCardiovascular disease
The Lancet Healthy Longevity
Discontinuation of statins for primary prevention of atherosclerotic cardiovascular disease in adults aged 75 years or older (SAGA/SITE): a multicentre, open-label, pragmatic, non-inferiority randomised trial
Randomised trial in 1,180 peopleStatins
The Cochrane Database of Systematic Reviews
Higher blood pressure targets for hypertension in older adults
Meta-analysis of randomised trialsHypertension